106 related articles for article (PubMed ID: 6547748)
1. [Clinical application of KM 2210 (estradiol-chlorambucil) in patients with advanced prostatic carcinoma].
Isurugi K
Gan No Rinsho; 1984 Jun; 30(7):810-8. PubMed ID: 6547748
[TBL] [Abstract][Full Text] [Related]
2. [A new anti-cancer agent, bestrabucil (KM 2210): I. Concentration in the serum and tissue in urogenital tumors].
Nasu Y; Saegusa M; Hara M; Ochi J; Akagi T; Obama T; Tsushima T; Yoshimoto J; Ozaki Y; Matsumura Y
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1116-21. PubMed ID: 3566306
[TBL] [Abstract][Full Text] [Related]
3. [Bestrabacil: a possible target-oriented anticancer agent].
Ohsawa N; Yamazaki Z; Wagatsuma T; Isurugi K
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2115-24. PubMed ID: 6548354
[TBL] [Abstract][Full Text] [Related]
4. [Phase I study of bestrabucil (KM 2210)].
Kamei H; Takenaka K; Goto T; Suga S; Fugiwara A; Nakao I; Agatsuma T; Fujita K; Isurugi K; Kubota T
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2208-15. PubMed ID: 3755019
[TBL] [Abstract][Full Text] [Related]
5. A phase II multi-institutional study of estra-1,3,5(10)-triene-3,17 beta-diol, 3-benzoate, 17[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1- oxobutoxy]acetate] (KM2210), a novel antitumor agent, for advanced and recurrent breast carcinoma.
Kubota T; Abe O; Izuo M; Watanabe H; Enomoto K; Ohsawa N; Kuno K
Anticancer Res; 1993; 13(6B):2361-5. PubMed ID: 8135468
[TBL] [Abstract][Full Text] [Related]
6. [Clinical trial of bestrabucil (KM 2210) on hematopoietic malignancies].
Nishikawa M; Uemura Y; Matsuoka N; Ohno T; Katayama N; Tomeoku M; Kobayashi T; Kita K; Tanaka H; Minami N
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2155-9. PubMed ID: 3521494
[TBL] [Abstract][Full Text] [Related]
7. [Early phase II trial of bestrabucil in hematological malignancies].
Nagura E; Ohno R; Yamada K; Akao Y; Naito K; Nishikawa M; Tanaka H; Shirakawa S; Ono Y; Ezaki K
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2216-22. PubMed ID: 3459398
[TBL] [Abstract][Full Text] [Related]
8. [Clinical trial of bestrabucil (KM 2210) in hematopoietic malignancies].
Naito K; Kubo K; Akao Y; Hiraiwa A; Naoe T; Yamada K
Gan No Rinsho; 1986 Sep; 32(11):1443-50. PubMed ID: 2877106
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic results in recurrent breast cancer with the use of Bestrabucil (KM2210)].
Ueda T; Sakai K; Morimoto K; Nakatani S
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3285-9. PubMed ID: 3688892
[TBL] [Abstract][Full Text] [Related]
10. [A case of carcinoma in the lower abdomen treated successfully with oral administration of bestrabucil].
Tsujitani S; Baba H; Korenaga D; Haraguchi M; Hiramoto Y; Okamura T; Sugimachi K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2960-3. PubMed ID: 3662547
[TBL] [Abstract][Full Text] [Related]
11. [KM 2210 therapy for chronic lymphocytic leukemia].
Mori M; Murai Y; Miwa A; Fukayama M; Ikebuchi K; Nakamura N; Kaise M
Gan No Rinsho; 1983 Dec; 29(15):1788-90. PubMed ID: 6689433
[TBL] [Abstract][Full Text] [Related]
12. [Tumor-oriented anti-cancer agent with estrogen as a carrier].
Ohsawa N; Yamazaki Z
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1065-71. PubMed ID: 3291767
[TBL] [Abstract][Full Text] [Related]
13. [Clinical effects of bestrabucil (KM2210) in bladder cancer].
Nasu Y; Saegusa M; Ochi J; Hara M; Akagi T; Obama T; Yoshimoto J; Matsumura Y; Ohmori H; Tsushima T
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3155-6. PubMed ID: 3674900
[No Abstract] [Full Text] [Related]
14. [Prostatic carcinoma: metabolic effect of percutaneous beta-estradiol (author's transl)].
Steg A; Benoit G; Limouzin-Lamotte A; Mahoudeau J; Caillens M; Raichvarg D
Nouv Presse Med; 1979 Nov; 8(46):3801-2. PubMed ID: 534245
[TBL] [Abstract][Full Text] [Related]
15. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
16. [Bestrabucil-induced complete remission in a case of follicular lymphoma, medium-sized cell type, stage IV (leukemic)].
Hirano M; Shirakawa S
Gan No Rinsho; 1986 Sep; 32(11):1491-4. PubMed ID: 3534347
[TBL] [Abstract][Full Text] [Related]
17. Polyestradiol phosphate and ethinyl estradiol in treatment of prostatic carcinoma.
Lindstedt E
Scand J Urol Nephrol Suppl; 1980; 55():95-7. PubMed ID: 6938044
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
19. [A case of breast carcinoma with lung metastasis].
Okayasu T; Masuda T; Kawabata M; Imai T; Hashimoto M; Inoue K; Tanabe T
Gan No Rinsho; 1987 Jun; 33(6):720-2. PubMed ID: 3599480
[TBL] [Abstract][Full Text] [Related]
20. The role of somatostatin analogues in complete antiandrogen treatment in patients with prostatic carcinoma.
Vainas G; Pasaitou V; Galaktidou G; Maris K; Christodoulou K; Constantinidis C; Kortsaris AH
J Exp Clin Cancer Res; 1997 Mar; 16(1):119-26. PubMed ID: 9148872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
